Biotech Co. Celldex Completes $90M Curagen Buy
By Elaine Meyer · October 2, 2009, 5:24 PM EDT
Biotechnology company Celldex Therapeutics Inc. has completed its purchase of fellow cancer drug maker Curagen Corp. for more than $90 million, the companies have announced....
To view the full article, register now.